Fundraising Fox
/Companies
Sign in

Strand Therapeutics

Boston, US · 16 known investors

Find your way into Strand Therapeutics

1,838 people in our graph can introduce you to the Strand Therapeutics team.

Sign up to see every warm intro you have to Strand Therapeutics

  • Paths you didn't know you had: your email and LinkedIn already hold routes to the Strand Therapeutics team. We find them
  • 2nd- and 3rd-degree connections: the friend-of-a-friend routes you can't see from your own inbox or LinkedIn
  • Answers now, not in days: momentum is everything in a raise. Skip asking around whether someone knows someone

Days of research, done the moment you sign in, with every route ranked by how warm it is.

Sign up with GoogleAlready have an account? Log in

Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.

Biotech

Founders & leadership

TKTasuku Kitada
Tasuku KitadaCo-founderTasuku Kitada has worked as a scientist, biotech analyst, and biotech executive with experience in multiple countries including the U.S., EU, and Japan. He is co-founder and executive officer at Strand Therapeutics, which develops programmable mRNA therapies for cancer and other diseases.
JBJacob Becraft
Jacob BecraftCo-founderJacob Becraft holds a PhD in Biological Engineering and Synthetic Biology from MIT and a BS in Chemical and Biomolecular Engineering from the University of Illinois at Urbana-Champaign. As co-founder and CEO of Strand Therapeutics, he leads development of programmable mRNA therapies; his research at MIT focused on synthetic biology platforms for mRNA engineering.
SK
Samta KunduExecutive

Board

JKJeb Keiper
Jeb KeiperBoard directorInvestor at Third Rock Ventures
AAAla Alenazi
Ala AlenaziBoard directorPrincipal at Ascension Ventures
PEPegah Ebrahimi
Pegah EbrahimiBoard directorCo-founder & Managing Partner at FPV
JBJory Bell
Jory BellBoard directorGeneral Partner at Playground Global

Investors · 16

Kinneviklisted by KinnevikStockholm

How we know: Kinnevik's portfolio page · funding news · forbes.com · Not right? Tell us

Playground Globallisted by Playground GlobalPalo Alto · $1M – $20M

How we know: Playground Global's portfolio page · a partner's Signal profile · funding news · forbes.com · Not right? Tell us

Amgen VenturesreportedThousand Oaks · $1M – $3M

How we know: funding news · forbes.com · Not right? Tell us

ANRIreportedTokyo

How we know: funding news · Not right? Tell us

FPVreportedJackson · $100K – $5M

How we know: a partner's Signal profile · board seat on SEC Form D · Not right? Tell us

ICONIQreportedSan Francisco

How we know: funding news · forbes.com · Not right? Tell us

LG Technology VenturesreportedSilicon Valley

How we know: funding news · fiercebiotech.com · Not right? Tell us

Regeneron Venturesreported

How we know: forbes.com · Not right? Tell us

Third Rock VenturesinferredBoston · $100K – $5Mvia Jeb Keiper · board

How we know: board seat on SEC Form D · Not right? Tell us

Also in the syndicate · 6

Alderline GroupEli LillyFPV VenturesGradiant Corp.JIC-VGIPlaygroundlead

Funding

SEC filings, press & company announcements

$319.1M disclosed across 4 of 6 rounds · 2019–2025

▶$108.1MraisedMar 2026 · 10 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Jeb KeiperDirector
  • Ala AlenaziDirector
  • Pegah EbrahimiDirector
  • Tasuku KitadaExecutive Officer, Director, Promoter
  • Samta KunduExecutive Officer
  • Jory BellDirector
  • Jacob BecraftExecutive Officer, Director, Promoter
Offering amount
$120.1M
Amount sold
$108.1M
First sale
May 2025
Incorporated
Corporation, Delaware
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$52.1MraisedJul 2021 · 13 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tasuku KitadaExecutive Officer, Director, Promoter
  • Jacob BecraftExecutive Officer, Director, Promoter
  • Samta Jacob KunduExecutive Officer
  • Jory BellDirector
Offering amount
$52.1M
Amount sold
$52.1M
First sale
May 2021
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗
▶$5.9MraisedJun 2019 · 11 investors · Biotechnology
Rule 506(b)
Officers, directors & promoters on the filing
  • Tasuku KitadaExecutive Officer, Director, Promoter
  • Jory BellDirector
  • Jacob BecraftExecutive Officer, Director, Promoter
Offering amount
$5.9M
Amount sold
$5.9M
First sale
May 2019
Incorporated
Corporation, Delaware, 2017
Federal exemptions
06b
Full filing on SEC EDGAR ↗

Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.

Founder mafia

3 people who came through Strand Therapeutics went on to found or lead other companies.

Shannon DahlStrategic Advisory BoardFounded Humacyte +1Jake BecraftExecutive Officer, Director, PromoterFounded StrandtxTasuku KitadaExecutive Officer, Director, PromoterFounded Strandtx

Frequently asked questions

What does Strand Therapeutics do?
Develops programmable mRNA therapies that last longer and target cells more precisely for cancer and other diseases.
Who founded Strand Therapeutics?
Strand Therapeutics was founded by Tasuku Kitada, Jacob Becraft.
Who are Strand Therapeutics's investors?
Strand Therapeutics's investors include JIC Venture Growth Investments, Kinnevik, Playground Global, Amgen Ventures, ANRI, FPV, ICONIQ, LG Technology Ventures and 2 more.
How much funding has Strand Therapeutics raised?
Strand Therapeutics has disclosed $319.1M raised across 4 of its 6 known rounds.
Where is Strand Therapeutics headquartered?
Strand Therapeutics is headquartered in Boston, US.